<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item><item key="slug">bl2-cells-stimulated-with-b-cell-specific-paracrin</item><item key="factor_count">2</item><item key="sample_count">22</item><item key="tags"><item>burkitt lymphoma</item><item>cell</item><item>line</item><item>lymphoma</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-42660</item><item key="id">2552</item><item key="name">BL2 cells stimulated with B cell specific paracrine stimuli</item></item><item><item key="slug">expression-data-from-the-rituximab-resistant-lymph</item><item key="factor_count">2</item><item key="sample_count">4</item><item key="tags"><item>burkitt lymphoma</item><item>cell</item><item>disease</item><item>line</item><item>lymphoma</item><item>mantle cell lymphoma</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-60327</item><item key="id">4804</item><item key="name">Expression data from the rituximab-resistant lymphoma cell lines and the parental cell lines</item></item><item><item key="slug">dual-targeting-of-myc-and-cyclon-by-bet-bromodomai</item><item key="factor_count">1</item><item key="sample_count">12</item><item key="tags"><item>b-cell lymphoma</item><item>burkitt lymphoma</item><item>cell</item><item>disease</item><item>hodgkin lymphoma</item><item>lymphoma</item><item>non-hodgkin lymphoma</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-46873</item><item key="id">2411</item><item key="name">Dual targeting of MYC and CYCLON by BET bromodomain inhibition optimizes Rituximab response in lymphoma.</item></item><item><item key="slug">lef1-in-burkitt-lymphoma</item><item key="factor_count">2</item><item key="sample_count">6</item><item key="tags"><item>burkitt lymphoma</item><item>cell</item><item>follicular lymphoma</item><item>genome</item><item>joint</item><item>lymphocyte</item><item>lymphoma</item><item>mantle cell lymphoma</item><item>marginal zone lymphoma</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-42637</item><item key="id">2415</item><item key="name">LEF1 in Burkitt lymphoma</item></item><item><item key="slug">mir-28-expression-in-the-burkitt-lymphoma-cell-lin</item><item key="factor_count">4</item><item key="sample_count">24</item><item key="tags"><item>burkitt lymphoma</item><item>cell</item><item>hodgkin lymphoma</item><item>line</item><item>lymphoma</item><item>non-hodgkin lymphoma</item><item>spindle</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-56268</item><item key="id">2008</item><item key="name">miR-28 expression in the Burkitt lymphoma cell line P3HR1</item></item><item><item key="slug">molecular-classification-of-aids-related-lymphomas</item><item key="factor_count">5</item><item key="sample_count">17</item><item key="tags"><item>aids</item><item>b-cell lymphoma</item><item>burkitt lymphoma</item><item>cancer</item><item>cell</item><item>diffuse large b-cell lymphoma</item><item>lymphoma</item><item>volume</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-17372</item><item key="id">3366</item><item key="name">Molecular Classification of AIDS-Related Lymphomas [including third-party data]</item></item><item><item key="slug">gene-expression-changes-in-subclones-of-a-burkitt</item><item key="factor_count">2</item><item key="sample_count">12</item><item key="tags"><item>burkitt lymphoma</item><item>cell</item><item>line</item><item>lymphoma</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-42867</item><item key="id">2573</item><item key="name">Gene expression changes in subclones of a Burkitt lymphoma cell line with different patterns of EBV latent infection</item></item><item><item key="slug">transcription-profiling-by-array-of-human-lymph-no</item><item key="factor_count">2</item><item key="sample_count">16</item><item key="tags"><item>burkitt lymphoma</item><item>cancer</item><item>lymph</item><item>lymphoma</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-26673</item><item key="id">3930</item><item key="name">Transcription profiling by array of human lymph node tissue from patients with Burkitt lymphoma</item></item><item><item key="slug">expression-data-from-treatment-induced-senescence</item><item key="factor_count">2</item><item key="sample_count">24</item><item key="tags"><item>burkitt lymphoma</item><item>cell</item><item>lymph</item><item>lymphoma</item><item>protein</item></item><item key="species">mouse</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-31099</item><item key="id">6569</item><item key="name">Expression data from treatment-induced senescence in mouse Emu-myc B-cell lymphoma model</item></item><item><item key="slug">synergy-between-pi3k-signaling-and-myc-in-burkitt</item><item key="factor_count">2</item><item key="sample_count">6</item><item key="tags"><item>b-cell lymphoma</item><item>burkitt lymphoma</item><item>cell</item><item>disease</item><item>lymphoma</item><item>surface</item></item><item key="species">mouse</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-35219</item><item key="id">6757</item><item key="name">Synergy between PI3K Signaling and MYC in Burkitt Lymphomagenesis</item></item></data></biogps>
